A study sponsor requests that an IRB expedite review of a protocol to meet a drug development deadline. What is the appropriate IRB response?
-
A
Expedite review if the sponsor covers additional administrative fees
-
B
Accommodate the request only if the protocol qualifies for expedited review under 45 CFR 46.110 categories
-
C
Approve the protocol provisionally and conduct full review afterward
-
D
Grant a 30-day extension to allow sponsor to revise the protocol